Erythropoietin Doping in Athletes: Possible Detection Through Measurement of Fibrinolytic Products

• REFERENCES

• 1 Over J, Sixma JJ, Bruïne MH, Trieschnigg MC, Vlooswijk RA, Beeser-Visser NH, Bouma BN. Survival of 125-iodine labeled Factor VIII in normals and patients with classic hemophilia. Observation on the heterogeneity of human Factor VIII. J Clin Invest 1978; 62: 223-234
• 2 Nankivell BJ, Koutts J, Harris DCH. Human recombinant erythropoietin (rHuEpo) stimulates platelet production and thrombosis. Kidney Int 1990; 38: 559 (abstract)
• 3 Akizawa T, Kinugasa E, Kitaoka T, Koshikawa S. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients. Nephron 1991; 58: 400-406
• 4 Davis RB, Boyd DG, McKinney ME, Jones CC. Effects of exercise and exercise conditioning on blood platelet function. Med Sci Sport Exerc 1990; 22: 49-53
• 5 Abels R. Review of hematologic effects of erythropoietin. Semin Nephrol 1990; 10: 01-10
• 6 Jelkmann W. Renal erythropoietin: properties and production. Rev Physiol Biochem Pharmacol 1986; 104: 140-179
• 7 Szewczuk J, Mazerska M, Malyszko J, Kalinowski M, Mysliwiec M. Increase in fibrinolytic activity after erythropoietin therapy. Thromb Haemostas 1992; 67: 284